Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.

Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label advances from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA 403 Forbidden error page is displayed, blocking access to the study record content while the site header and footer remain visible.SummaryDifference18%

- Check55 days agoChange DetectedNew NIH funding line added (2019 U.S. NIH Grant/Contract), and the page revision tag updated to Revision: v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor system update. No substantive study information or settings appear to be affected.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page's revision label was updated to v3.6.4, indicating a minor internal update to the study record.SummaryDifference0.1%

Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.